Specialty intelligence

Infectious Disease Reimbursement Alerts

9 active CMS and MAC reimbursement alerts affect Infectious Disease billing teams (High-priority changes active) — most recent: FDA Approval: ZEVTERA (CEFTOBIPROLE MEDOCARIL SODIUM) — Type 1 - New Molecular Entity, effective 2024-04-03. Monitored daily across CMS, all seven MACs, and the Federal Register.

Daily CMS policy updates, MAC LCD revisions, and coding guidance for Infectious Disease billing teams. All alerts sourced directly from CMS, MAC contractor sites, and the Federal Register.

High-priority alerts active

Total alerts

9

Average signal

45/100

Sources monitored

15+

Latest Infectious Disease alerts

9

FDA Approval: ZEVTERA (CEFTOBIPROLE MEDOCARIL SODIUM) — Type 1 - New Molecular Entity

Infectious Disease · Effective 2024-04-03

FDA Approval: ZYVOX (LINEZOLID) — Type 3 - New Dosage Form

Infectious Disease · Effective 2000-04-18

FDA Approval: VANCOMYCIN HYDROCHLORIDE (VANCOMYCIN HYDROCHLORIDE) — Type 3 - New Dosage Form

Infectious Disease · Effective 1993-04-29

+ 6 more Infectious Disease alerts

Sign in to see the full alert feed →

What is Infectious Disease reimbursement leakage costing you?

Calculate your ROI with Infectious Disease-specific CMS benchmarks pre-populated.

Calculate ROI →

MAC contractor coverage

Infectious Disease billing is subject to both national CMS policy and regional MAC contractor Local Coverage Determinations (LCDs). CLV Intelligence monitors all MAC contractor sites — Noridian, CGS, First Coast, NGS, Novitas, Palmetto GBA, and WPS — for LCD updates affecting Infectious Disease codes. Coverage criteria vary by contractor jurisdiction.

NoridianCGS AdministratorsFirst CoastNational Government ServicesNovitas SolutionsPalmetto GBAWPS

Get Infectious Disease alerts by email — free

Weekly digest of CMS and MAC policy changes for Infectious Disease billing teams.

Frequently asked questions

What MAC contractors issue LCDs for Infectious Disease billing?

Infectious Disease billing is subject to regional Local Coverage Determinations (LCDs) from all seven Medicare Administrative Contractors: Noridian, CGS Administrators, First Coast Service Options, National Government Services, Novitas Solutions, Palmetto GBA, and WPS Government Health Administrators. Coverage criteria and medical necessity requirements vary by contractor jurisdiction. CLV Intelligence monitors all MAC contractor sites daily for LCD updates affecting Infectious Disease codes.

How often does CMS update Infectious Disease reimbursement policy?

CMS updates the Physician Fee Schedule annually, effective January 1, with proposed rules published in the summer and final rules in November. MAC contractors issue LCD updates on a rolling basis throughout the year with no fixed schedule. The Federal Register publishes proposed and final rules affecting Infectious Disease reimbursement on a continuous basis. CLV Intelligence monitors all three sources daily and surfaces updates by signal strength.

What is a Local Coverage Determination (LCD) and how does it affect Infectious Disease billing?

A Local Coverage Determination (LCD) is a decision by a Medicare Administrative Contractor specifying under what clinical circumstances a particular service is covered within its geographic jurisdiction. For Infectious Disease billing teams, LCDs define medical necessity criteria, covered diagnoses, and documentation requirements for specific procedures. Failure to comply with LCD requirements is among the most common causes of Medicare claim denial in Infectious Disease practices.

Reimbursement guides & resources

Plain-language guides to the policy cycles that drive Infectious Disease reimbursement — the fee schedule, ICD-10, HCPCS, and Local Coverage Determinations.

Other specialties